Antifungal Drugs Market Scope And Analysis

  • Report Code : TIPRE00003745
  • Category : Life Sciences
  • No. of Pages : 169
Buy Now

Analyse de la dynamique et de la portée du marché des médicaments antifongiques d'ici 2025-2031

Buy Now

Antifungal Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 3.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type d'infection
  • infection fongique superficielle et infection fongique systémique
By Type de médicament
  • échinocandines
  • azoles
  • polyènes
  • allylamines
By Indication thérapeutique
  • aspergillose
  • dermatophytose
  • candidose
  • autres
By Forme posologique
  • médicaments
  • pommade
  • poudre
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc.
  • Sanofi S.A.
  • Gilead Sciences, Inc.
  • Merck And Co., Inc.
  • Scynexis Inc.
  • Novartis International AG
  • Abbott Laboratories
  • Bayer AG
  • Glenmark Pharmaceutical